Articles tagged with 'Regenerative Medicine' & 'Neuro' | Cedars-Sinai Medical Center

Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus and short-term storage of information.The study detailing …

Neuroprosthetics, a technology that allows the brain to control external devices such as robotic limbs, is beginning to emerge as a viable option for patients disabled by amputation or neurological conditions such as stroke. Cedars-Sinai …

Ueli Rutishauser, PhD, is professor of Neurosurgery, Neurology and Biomedical Sciences and director of Human Neurophysiology Research and the Center for Neural Science and Medicine at Cedars-Sinai. He studies the mechanisms behind learning, memory …

Artist Syril Strickler was 47 when she had her first epileptic seizure, waking up in the hospital after neighbors found her unconscious in the street. For 10 years, seizures every few weeks brought her life to a virtual standstill—until Cedars-Sinai …

Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai. She will treat …

Two leading multiple sclerosis (MS) experts—Nancy Sicotte, MD, chair of the Department of Neurology and director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai, and Pascal Sati, PhD, director of the Neuro Imaging Program in the Department …

Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure. Their findings, detailed in a paper published in the peer-reviewed journal Science, could lead to the development …

Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety. In a study published in the peer-reviewed journal Lab on …

Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is …

Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, …

A new Cedars-Sinai study might have cracked the mystery surrounding the cause of a specific type of back pain.Almost 40% of the adult population experiences low back pain due to degenerating disks in the spine, but medical science hasn’t understood …

Sitting in his cardiologist’s office at Cedars-Sinai one Friday afternoon in 2022, Cornelius Albert suddenly was unable to move or speak.“I had an attack,” said Albert, 76, who runs a court filing service and lives in View Park. “My limbs went limp …

Investigators from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai are advancing stem cell technology to treat degenerative diseases of the eye. In one recent study, they determined the optimal dose and surgical method for …

The first prospective study comparing outcomes in patients with pituitary apoplexy—sudden bleeding or death of a pituitary tumor—found that individuals managed medically fared as well as those treated surgically in the majority of cases. The …

Parents often miss the signs that their child has epilepsy, according to Deborah Holder, MD, a neurologist at Cedars-Sinai Guerin Children’s and a pediatric epilepsy expert.“Every day in clinic I see children who have had for years what many people …

Cedars-Sinai investigators have joined with colleagues from seven regenerative medicine institutes in the Los Angeles region to form a new working group that will share resources and maximize the impact of state funding.“The goal of this group is to …

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like …

Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the …

Two new publications from Cedars-Sinai neuroscientists are helping to advance scientific understanding of the complex molecular and cellular processes involved in Alzheimer’s disease—and the body’s innate immune mechanisms for fighting against the …

A Cedars-Sinai study has identified a group of brain cells in laboratory mice that regulate stress-induced feeding and calorie expenditure, with a more pronounced effect in females than in males.The discovery, published in the peer-reviewed journal …

In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called …

Donnè Ward, a Mira Costa High School sophomore, has always been interested in medicine. So interested that his grandmother, Trena Lawson, said he was 5 when he first talked about becoming a doctor.  As a member of the Los Angeles Clippers …

Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.The findings, published in the peer-reviewed journal …

Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment that has received approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.  “This is the most promising …

Building on its visionary investment in Cedars-Sinai’s neurosurgery scholarship program, The Ray Charles Foundation has donated a second gift of $1 million to support critical training and research to advance the neurosciences.The Ray Charles …

Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the …

The Register and Gizmodo recently interviewed Arun Sharma, PhD, a stem cell biologist in the Smidt Heart Institute, and Clive Svendsen, PhD, executive director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, to discuss the …

Cedars-Sinai investigators are working to develop a more effective treatment for one of the most common and hard-to-heal musculoskeletal injuries: torn tendons. Investigators led by Dmitriy Sheyn, PhD, assistant professor in the …

Investigators at Cedars-Sinai have created computer-generated models to bridge the gap between “test tube” data about neurons and the function of those cells in the living brain. Their study, published in the peer-reviewed journal Nature …

The first prospective study comparing outcomes in patients with pituitary apoplexy—sudden bleeding or death of a pituitary tumor—found that patients managed medically fared as well as those treated surgically in the majority of cases. The …